MedTrace Logo

Utility of Restrata With Split Thickness Skin Graft to Reconstruct the Forearm Donor Site

NCT04829331 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2023-04-18

Study results available
· View outcomes & findings →

Summary

Understand association between use of Restrata (Acera Surgical Inc., St. Louis, MO) in forearm flap reconstruction with donor site healing and function

Conditions

  • Wound Heal

Interventions

DEVICE

Restrata

Restrata is a sterile, single use device intended for use in local management of wounds

Sponsors & Collaborators

  • Acera Surgical, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-09
Primary Completion
2022-01-01
Completion
2022-01-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04829331 on ClinicalTrials.gov